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an “index subject” who is not simultaneously a “pro-
band.” Moreover, our conclusions hold regardless of
whether the marginal probabilities of the two siblings
being affected are equal: if they are equal, then condi-
tioning on the proband will give an unbiased estimate
(our eq. [5]); if they are not equal, then conditioning
on the proband who has been defined as such prior to
ascertainment will also give an unbiased estimate (our
eq. [4]).
Finally, to end on a more positive note, we look at
the broader context of Guo’s paper.We have investigated
only two-child families ( ), and we have investi-k p 2
gated those selected under single ascertainment only.
Guo may be correct in asserting that there is ascertain-
ment bias in larger families. Moreover, we are certainly
not defending the use of lS, since we suspect that this
measure probably is subject to ascertainment bias when
ascertainment is other than single (also see Olson and
Cordell 2000). We applaud Guo’s work on this sub-
ject but believe that it will be more useful if he clarifies
the definition of sibling recurrence risk in ascertained
families.
Acknowledgments
This work was supported by National Institutes of Health
grants MH-57813 (to P.J.W.) and MH-48858 and DK-31813
(both to S.E.H.).
PRIYA J. WICKRAMARATNE AND SUSAN E. HODGE
Department of Psychiatry, College of Physicians and
Surgeons, and Division of Biostatistics, Mailman
School of Public Health, Columbia University, and
Division of Clinical and Genetic Epidemiology, New
York State Psychiatric Institute, New York
References
Bailey JM, Benishay DS (1993) Familial aggregation of female
sexual orientation. Am J Psychiatry 150:272–277
Ewens WJ, Shute NCE (1986) The limits of ascertainment.
Ann Hum Genet 50:399–402
Guo SW (1998) Inflation of sibling recurrence-risk ratio, due
to ascertainment bias and/or overreporting. Am J Hum Ge-
net 63:252–258
Hodge SE, Vieland VJ (1996) The essence of single ascertain-
ment. Genetics 144:1215–1223
Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR,
Ross RK, Henderson BE (1995) Evidence of an X-linked or
recessive genetic prostate cancer risk. Nat Med 1:827–829
Morton NE (1959) Genetic tests under incomplete ascertain-
ment. Am J Hum Genet 11:1–16
Narod SA, Dupont A, Cusan L, Diamond P, Gomez J-L, Sub-
uru R, Labrie F (1995) The impact of family history on early
detection of prostate cancer. Nat Med 1:99–101
Olson JM, Cordell HJ (2000) Ascertainment bias in the esti-
mation of sibling genetic risk parameters. Genet Epidemiol
18:217–235
Pillard RC, Weinrich JD (1986) Evidence of familial nature of
male homosexuality. Arch Gen Psychiatry 43:808–812
Sham P (1998) Statistics in human genetics. Arnold, London
Stene J (1977) Assumptions for different ascertainmentmodels
in human genetics. Biometrics 33:523–527
Address for correspondence and reprints: Dr. Priya Wickramaratne,
NYSPI—Unit 24, 1051 Riverside Drive, New York, NY 10032. E-mail:
wickramp@child.cpmc.columbia.edu
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6803-0028$02.00
Am. J. Hum. Genet. 68:810–812, 2001
Reply to Wickramaratne and Hodge
To the Editor:
Sibling recurrence-risk ratio is perhaps the most widely
used measure for familial aggregation of complex dis-
eases and is often used as a measure of genetic effect. It
is frequently used in power calculations in gene-mapping
studies and in exclusion mapping. It is little known
among human geneticists, however, that familial clus-
tering of risk factors of an environmental nature also
can elevate sibling recurrence-risk ratio, even in the com-
plete absence of any genetic (hereditary) factors (Guo
2000a). In addition, ascertainment bias in estimation of
sibling recurrence-risk ratio is frequently overlooked or
simply ignored in genetic epidemiological studies (Guo
1998). I am very pleased to see the letter of Wickra-
maratne and Hodge (henceforth, “W&H”), which at-
tempts to further take up this issue.
As a measure of familial aggregation, the original def-
inition of sibling recurrence-risk ratio (see, e.g., Risch
1990) is very intuitive and appealing. My paper (Guo
1998) demonstrates that, when the actual use of this
measure deviates from its original definition (i.e., defi-
nitions 2 and 3 in Guo 1998), the estimation of sibling
recurrence-risk ratio can be artificially inflated if there
is ascertainment bias and/or overreporting under single
and multiple ascertainment schemes. It should be noted
that I did not define sibling recurrence risk in ascertained
families, as claimed by W&H, but, rather, that I pointed
out the consequence of “misunderstanding of the orig-
inal definition of lS” (Guo 1998).
W&H assert that Guo (1998) finds bias “only because
he permits the sibling who is being conditioned on… to
be other than the sibling through whom the family is
ascertained,” and that my definition “does not corre-
spond to the definition that researchers in fact use,” at
least for two-child families. Furthermore, they claim
that, under their definition, when the sibship size (k) is
two, there is no ascertainment bias under single ascer-
tainment in the estimation.
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In many genetic epidemiological studies, especially
those cross-sectional or longitudinal studies, researchers
often start with a cohort of or a sample of willing par-
ticipants in their studies, through whom their families
are further ascertained. Quite often, the disease statuses
of these participants are either apparently normal ini-
tially or are unknown and are to be determined by either
follow-up observations or subsequent diagnostic tests.
A case in point is a study of the impact of family history
on early detection of prostate cancer (Narod et al. 1995),
which also was mentioned in W&H. In the study by
Narod et al., “a total of 26,781 men, aged 45 and above,
was selected from the electoral lists and sent a written
invitation to participate in the screening project… Of
these, 7,277 (27.2%) indicated their willingness to par-
ticipate (in the study)” (Narod et al. 1995). The subjects
were then asked to undergo annual diagnostic screening
for prostate cancer. At the publication of the study,
“prostate cancer was detected in 10.2% of subjects who
reported a brother with prostate cancer. This frequency
was 2.62 times greater than for men with no affected
first-degree relative” (Narod et al. 1995), a major find-
ing, which was also cited by Monroe et al. (1995).
In this study, the sib being conditioned on (the subject’s
brother) was obviously different from the sib through
whom the family was ascertained (the subject himself), as
it was in the study reported by Monroe et al. (1995).
Contrary to what W&H claim, these studies do not “al-
ways treat the proband as the ‘index subject.’” If no mea-
sure is taken to adjust for ascertainment and for sibship
size, it is very likely that the sibling recurrence-risk ratio
can be inflated. In view of this, I foundW&H’s assertion,
that “it is difficult for us to imagine a genetic or family
study that would use Guo’s definition,” troubling.
I also found W&H’s own definition of sibling recur-
rence risk unsettling—on two grounds. First, their def-
inition is not backward compatible with the original one.
A close inspection of W&H’s definition of sibling re-
currence risk (eq. (5) in W&H), which is given by
,∗K p P(2 siblings affected d ≥ 1 sibling affected, A)R
where A denotes the event that this sibship has been
ascertained, reveals that, when ascertainment bias is
completely absent, under the situation considered by
both Guo (1998) and W&H (2001),
∗K p P(2 siblings affected d ≥ 1 sibling affected)R
{ } { }p P(X p 1, X p 1 d X p 1 ∪ X p 1 )1 2 1 2
2p
p 22p p
p
p ! p
1 (1 p)
This indicates that, underW&H’s definition, the sibling
recurrence-risk ratio, lS, would be !1, even when there
is no familial aggregation. This, of course, is directly at
odds with the original definition (see Risch 1990).
Second, W&H’s definition of sibling recurrence-risk
ratio is clearly ascertainment dependent and is highly
likely to be sibship-size dependent, since they do not
provide the definition for sibship sizes greater than two.
This raises a serious question as to what they intend to
measure, since single ascertainment is just one of count-
less ascertainment schemes that are often unknown to
the investigator.
In summary, many genetic epidemiological studies do
not treat the proband as the “index subject,” which
W&H find objectionable. This is especially true for
cross-sectional or longitudinal studies. And W&H’s let-
ter actually raises more questions than they have solved:
If their definition is not compatible with the original one,
what does it truly measure in general cases? How should
we define sibling recurrence risk for non-single-ascer-
tainment schemes and/or for families with more than
two children? How can we define it when ascertainment
scheme is unknown? Nonrandom sampling is almost
always by necessity in genetic epidemiological studies.
For a huge body of literature either on genetic models
based on sibling recurrence-risk ratios or with estimated
sibling recurrence risks of various diseases, which ap-
parently has not usedW&H’s definition, should we trust
their results?
Despite these uncertainties, it seems certain that the
estimation of sibling recurrence risk can be artificially in-
flated if there is ascertainment bias and/or overreporting.
Furthermore, even if lS can be estimated accurately and
reliably, it usually tells us little about whether the familial
aggregation of disease is either genetic or environmental
(Risch et al. 1993; Guo 2000a and 2000b).
Acknowledgments
This work was supported, in part, by the National Institutes
of Health grant R01-GM56515.
SUN-WEI GUO
Department of Pediatrics, Max McGee Research
Center for Juvenile Diabetes, and Division of
Biostatistics, Health Policy Institute, Medical College
of Wisconsin, Milwaukee
References
Guo SW (1998) Inflation of sibling recurrence-risk ratio, due
to ascertainment bias and/or overreporting. Am J Hum
Genet 63:252–258
——— (2000a) Familial aggregation of environmental risk
factors and familial aggregation of disease. Am J Epidemiol
151:1121–1131
——— (2000b) Gene-environment interaction and the map-
812 Letters to the Editor
ping of complex traits: some statistical models and their
implications. Hum Hered 50:286–303
Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR,
Ross RK, Henderson BE (1995) Evidence of an X-linked or
recessive genetic prostate cancer risk. Nat Med 1:827–829
Narod SA, Dupont A, Cusan L, Diamond P, Gomez J-L,
Suburu R, Labrie F (1995) The impact of family history on
early detection of prostate cancer. Nat Med 1:99–101
Risch N (1990) Linkage strategies for genetically complex
traits. I. Multilocus models. Am J Hum Genet 46:222–228
Risch N, Squires-Wheeler E, Keats BJ (1993) Male sexual ori-
entation and genetic evidence. Science 262:2063–2065
Wickramaratne PJ, Hodge SE (2001) Estimation of sibling re-
currence-risk ratio under single ascertainment in two-child
families. Am J Hum Genet 68:807–810 (in this issue)
Address for correspondence and reprints: Dr. Sun-Wei Guo, Department of
Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road, MS
756, P.O. Box 26509, Milwaukee, WI 53226-0509. E-mail: swguo@mcw.edu
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6803-0029$02.00
